SUVEN PHARMACEUTICALS LTD.
NSE : SUVENPHARBSE : 543064ISIN
CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse
: Private
BSE642.30-7.9 (-1.22 % )
PREV CLOSE (Rs.) 650.20
OPEN PRICE (Rs.) 640.75
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5416
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE644.55 -5.85 (-0.9 % )
PREV CLOSE(Rs.) 650.40
OPEN PRICE (Rs.) 638.85
BID PRICE (QTY) 644.55 (50 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 70598
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Cah Flow
(Rs in Million)
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
| Profit Before Tax | 5597.30 | 6675.90 | 4676.74 | 4045.12 | 1578.67 |
| Adjustment | 313.38 | 406.34 | 364.81 | 346.03 | 139.25 |
| Changes In working Capital | 56.36 | -1939.66 | -121.73 | 542.11 | -883.26 |
| Cash Flow after changes in Working Capital | 5967.04 | 5142.58 | 4919.82 | 4933.26 | 834.66 |
| Cash Flow from Operating Activities | 4509.12 | 3300.00 | 3825.47 | 4069.17 | 504.05 |
| Cash Flow from Investing Activities | -1948.42 | -1361.38 | -3113.98 | -4134.47 | -654.80 |
| Cash Flow from Financing Activities | -2358.31 | -1564.81 | -756.62 | 73.22 | 259.78 |
| Net Cash Inflow / Outflow | 202.39 | 373.81 | -45.13 | 7.92 | 109.03 |
| Opening Cash & Cash Equivalents | 445.64 | 71.82 | 116.95 | 109.03 | NA |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | NA | NA | NA | NA | NA |
| Cash & Cash Equivalent of Subsidiaries under liquidations | NA | NA | NA | NA | NA |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | NA | NA | NA | NA | NA |
| Effect of Foreign Exchange Fluctuations | NA | 0.00 | 0.00 | 0.01 | NA |
| Closing Cash & Cash Equivalent | 648.03 | 445.64 | 71.82 | 116.95 | 109.03 |
